Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 2, Pages 420
Publisher
MDPI AG
Online
2018-02-15
DOI
10.3390/molecules23020420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytotoxic properties of a new organometallic platinum(ii) complex and its gold(i) heterobimetallic derivatives
- (2016) Maria Serratrice et al. DALTON TRANSACTIONS
- Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates
- (2016) Christoph A. Riedl et al. INORGANIC CHEMISTRY
- Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties
- (2016) F. Battistin et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Arene Osmium Complexes with Ethacrynic Acid-Modified Ligands: Synthesis, Characterization, and Evaluation of Intracellular Glutathione S-Transferase Inhibition and Antiproliferative Activity
- (2016) Gabriele Agonigi et al. ORGANOMETALLICS
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c
- (2015) Giarita Ferraro et al. CHEMICAL COMMUNICATIONS
- Easy To Synthesize, Robust Organo-osmium Asymmetric Transfer Hydrogenation Catalysts
- (2015) James P. C. Coverdale et al. CHEMISTRY-A EUROPEAN JOURNAL
- Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
- (2015) Isolda Romero-Canelón et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design
- (2015) Joan J. Soldevila-Barreda et al. Nature Communications
- Development of anticancer agents: wizardry with osmium
- (2014) Muhammad Hanif et al. DRUG DISCOVERY TODAY
- Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells
- (2014) Sabine H. van Rijt et al. Metallomics
- Thiosulfoxide (Sulfane) Sulfur: New Chemistry and New Regulatory Roles in Biology
- (2014) John Toohey et al. MOLECULES
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Glutathione and mitochondria
- (2014) Vicent Ribas et al. Frontiers in Pharmacology
- Efficient and Rapid Synthesis of Chlorido-Bridged Half-Sandwich Complexes of Ruthenium, Rhodium, and Iridium by Microwave Heating
- (2013) Justus Tönnemann et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- New water-soluble ruthenium(II) cytotoxic complex: Biological activity and cellular distribution
- (2013) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Ruthenium-catalyzed reductive deamination and tandem alkylation of aniline derivatives
- (2013) Tetsuro Koreeda et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles
- (2013) Jinzhuan Wang et al. Chemical Science
- Probing the Interaction of Cisplatin with Cytochrome c by Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
- (2012) Ningbo Zhang et al. ANALYTICAL CHEMISTRY
- Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity
- (2012) Soledad Betanzos-Lara et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
- (2011) Michael Groessl et al. Metallomics
- Glutathione in Cancer Cell Death
- (2011) Angel L. Ortega et al. Cancers
- Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
- (2010) B M Madhok et al. BRITISH JOURNAL OF CANCER
- [Au2(phen2Me)2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties
- (2010) Maria A. Cinellu et al. ACS Medicinal Chemistry Letters
- Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
- (2009) Teni Boulikas EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Exploring metallodrug–protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound
- (2009) Angela Casini et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke
- (2009) Giuseppe Salemi et al. NEUROLOGICAL SCIENCES
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways
- (2008) Soumya Chatterjee et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started